Sharda Cropchem Ltd. · NSE:SHARDACROP
Sharda Cropchem — FY2025 Earnings Presentation
35 slides from Sharda Cropchem's earnings presentation, May 14, 2025
Slide 1: Exchange filing cover letter
14th May, 2025 To, National Stock Exchange of India BSE Limited Limited Phiroze Jeejeebhoi Tower, Exchange Plaza, 5th Floor, Plot No. Dalal Street, C/1, Mumbai – 400 001 G-Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Trading Symbol: SHARDACROP Scrip Code: 538666 Subject: Investors / Ana
Slide 2: Investor Presentation May 2025
SECURING HARVESTS, NURTURING FUTURES. Investor Presentation May 2025
Slide 3: Safe Harbor
SAFE HARBOR This presentation has been prepared by and is the sole responsibility of Sharda Cropchem Limited (the “Company”). By accessing this presentation, you are agreeing to be bound by the trailing restrictions. This presentation does not constitute or form part of any offer or invitation or in
Slide 4: About Sharda Cropchem Limited
About Sharda Cropchem Limited
Slide 5: Fast-growing global agrochemicals company
“We are a fast-growing global agrochemicals company with a peer position in the generic crop protection chemicals industry. Our vast and growing library of dossiers and IPRs provide us solid foundations for growth in the global marketplace, especially in Advanced Markets such as Europe, North Americ
Slide 6: Agrochemical Focused Company
AGROCHEMICAL FOCUSED COMPANY Sharda Cropchem is an Intellectual Property (IP) driven company engaged in marketing and distribution of wide range of formulations and generic active ingredients Asset Light Business Model : Efficiently channelizing time and resources for strengthening core competency o
Slide 7: Asset Light Business Model
ASSET LIGHT BUSINESS MODEL Overall Agrochemical Value Chain Sharda’s Operating Area √ √ √ √ Basic & Applied Active Ingredient Formulation & Marketing & Identification Registration Research Manufacturing Packaging Distribution Highly flexible operating model Manufacturing of AIs and Focus on identifi
Slide 8: Increasing Global Presence with a Widespread Distribution
INCREASING GLOBAL PRESENCE WITH A WIDESPREAD DISTRIBUTION CAPEX incurred in Presence Global Resource Distributors FY25* 80+ countries Deployment 525+ Rs. 420 Cr. across Europe, NAFTA, LATAM & RoW 500+ * Plus related revenue expenditure on registrations Over the years, the Company has built a strong
Slide 9: The Sharda Advantage
The Sharda Advantage Healthy Global Reach Wide Product Relationships with Range Suppliers One Stop Solution Quality with Faster Sales Provider for Crop Affordability Service Care Products
Slide 10: Way Forward
WAY FORWARD 1 2 Forward Integration - Build Sales Force Expand & Strengthen Distribution Presence ✓ Leverage market presence and execution capabilities ✓ Adopt the factory to farmer approach and be a one stop ✓ Expand geographical reach using existing library of dossiers solution provider ✓ Two-fold
Slide 11: Industry Outlook & Growth Drivers
INDUSTRY OUTLOOK & GROWTH DRIVERS Global crop protection INDUSTRY DRIVERS (In Billion USD) – CAGR of 4.3% 134.7 +4.3% A Growing Population: Global population is set to increase by 1.2 billion by 2030 and 2 billion by 2050, while the middle class will more than double to 4.9 billion by 2030 92.2 A gr
Slide 12: Experienced Management
Experienced Management Mr. Ramprakash V. Bubna Mr. Ashish Bubna Mr. Manish Bubna Chairman & Managing Director Whole Time Director Whole Time Director ✓ Holds a Bachelor’s Degree of Technology in Chemical ✓ Holds a Bachelor’s Degree in Commerce from the ✓ Holds a Bachelor’s Degree in Chemical Enginee
Slide 13: Q4 FY25 Financial Highlights
Q4 FY25 Financial Highlights
Slide 14: Q4 FY25: Segment Wise Highlights
Q4 FY25: SEGMENT WISE HIGHLIGHTS Cr. Agrochemical Segment Non-Agrochemical Segment TOTAL REVENUES 93% 92% 7% 8% % of Revenue 100% 100% +39% +42% +39% 1,691 138 1,829 1,215 97 1,312 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 On Consolidated Basis 13
Slide 15: Q4 FY25: Product Wise Highlights (Agrochemical Segment)
Q4 FY25: PRODUCT WISE HIGHLIGHTS (Agrochemical Segment) Cr. Herbicides Insecticides Fungicides TOTAL REVENUES (Agrochemical Segment) 45% 50% 18% 17% 38% 33% % of Revenue 100% 100% +57% +22% +39% 850 +31% 557 1,691 284 458 1,215 542 216 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25
Slide 16: Q4 FY25: Region Wise Breakup (Agrochemical Segment)
Q4 FY25: REGION WISE BREAKUP (Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Agrochemical Segment) 64% 66% 28% 29% +43% +45% +39% 1,115 493 1,691 782 340 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 1,215 LATAM Region RoW 3% 2% 5% 3% +19% -26% 39 60 33 44 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 Q4 FY24 Q4
Slide 17: Q4 FY25: Region Wise Breakup (Non-Agrochemical Segment)
Q4 FY25: REGION WISE BREAKUP (Non - Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Non - Agrochemical Segment) 17% 14% 62% 68% +19% +57% +42% 20 94 138 16 60 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 97 LATAM Region RoW 5% 8% 16% 9% +142% -19% 11 16 13 5 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 Q4 FY24
Slide 18: Q4 FY25: Financial Highlights
Q4 FY25 : FINANCIAL HIGHLIGHTS Cr. Revenues & GP Margin EBITDA Profit After Tax 34.6% 29.8% +16.2% +41.9% +39% 352 303 204 1,829 143 1,312 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 Q4 FY24 Q4 FY25 ✓ Revenue in Q4 FY25 increased by 39% primarily ✓ Gross Margins are at 29.8%. These margins are expected to impro
Slide 19: FY25 Financial Highlights
FY25 Financial Highlights
Slide 20: FY25: Segment Wise Highlights
FY25: SEGMENT WISE HIGHLIGHTS Cr. Agrochemical Segment Non-Agrochemical Segment TOTAL REVENUES 83% 87% 17% 13% % of Revenue 100% 100% +43% +4% +37% 3,773 547 4,320 524 2,639 3,163 FY24 FY25 FY24 FY25 FY24 FY25 On Consolidated Basis 19
Slide 21: FY25: Product Wise Highlights (Agrochemical Segment)
FY25: PRODUCT WISE HIGHLIGHTS (Agrochemical Segment) Cr. Herbicides Insecticides Fungicides TOTAL REVENUES (Agrochemical Segment) 50% 53% 21% 19% 29% 28% % of Revenue 100% 100% +52% +38% +43% 1,995 +28% 1,058 3,773 721 765 2,639 1,313 562 FY24 FY25 FY24 FY25 FY24 FY25 FY24 FY25 20
Slide 22: FY25: Region Wise Breakup (Agrochemical Segment)
FY25: REGION WISE BREAKUP (Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Agrochemical Segment) 57% 58% 31% 33% +45% +49% +43% 2,177 1,227 3,773 1,501 822 FY24 FY25 FY24 FY25 2,639 LATAM Region RoW 6% 5% 6% 5% +23% +11% 191 161 178 155 FY24 FY25 FY24 FY25 FY24 FY25 % of Revenue On Con
Slide 23: FY25: Region Wise Breakup (Non-Agrochemical Segment)
FY25: REGION WISE BREAKUP (Non - Agrochemical Segment) Cr. Europe NAFTA Region TOTAL REVENUES (Non - Agrochemical Segment) 16% 14% 58% 67% -9% +20% +4% 85 77 367 547 305 524 FY24 FY25 FY24 FY25 LATAM Region RoW 6% 9% 20% 10% +55% -47% 47 103 31 55 FY24 FY25 FY24 FY25 FY24 FY25 % of Revenue On Consol
Slide 24: FY25: Financial Highlights
FY25 : FINANCIAL HIGHLIGHTS Cr. Revenues & GP Margin EBITDA Profit After Tax 25.9% 29.9% +114.3% +854.1% 682 +37% 304 4,320 3,163 318 32 FY24 FY25 FY24 FY25 FY24 FY25 ✓ Revenue in FY25 increased by 37% primarily driven ✓ Gross Margins have increased by 400 bps to 29.9% and it is expected to further
Slide 25: Strong Balance Sheet
STRONG BALANCE SHEET Working Capital (in Days) Total Equity 158 days 118 days 192 Reduced Working Rs. 2,501 crores 157 Capital by 40 days 146 Rs. 2,237 crores as on Mar’24 123 111 83 Mar-24 Mar-25 Cash, Bank & Liquid Inventory Days Recievable Days Creditor Days Investments RoCE* RoE* Rs. 558 crores
Slide 26: Annexure
Annexure
Slide 27: Q4 & FY25 Financial Highlights
Q4 & FY25 FINANCIAL HIGHLIGHTS Cr. Particulars Q4 FY25 Q4 FY24 Y-o-Y FY25 FY24 Y-o-Y Revenue from Operations 1,828.5 1,312.1 39% 4,319.9 3,163.0 37% COGS 1,284.5 858.3 3,028.1 2,342.4 Gross Profit 544.0 453.8 20% 1,291.8 820.6 57% Gross Margin % 29.8% 34.6% 29.9% 25.9% Employee Expenses 18.2 14.7 52
Slide 28: Balance Sheet
BALANCE SHEET Cr. EQUITY & LIABILITIES Mar-25 Mar-24 ASSETS Mar-25 Mar-24 Equity Non-current assets Equity share capital 90.2 90.2 Property, plant and equipment 3.0 3.8 Other equity 2,410.3 2,146.9 Right to use assets 7.2 14.4 Equity attributable to equity holders of the Company 2,500.6 2,237.1 Good
Slide 29: Cash Flow Statement
CASH FLOW STATEMENT Cr. Particulars FY25 FY24 Profit Before Tax 378.3 71.9 Adjustments 286.8 272.8 Operating profit before working capital changes 665.1 344.6 Changes in working capital -30.5 47.0 Cash generated from operations 634.6 391.7 Direct taxes paid (net of refund) -31.0 -50.4 Net Cash from
Slide 30: Key Financial Performance Indices
KEY FINANCIAL PERFORMANCE INDICES Cr. Revenue EBITDA & EBITDA Margin* Profit After Tax & PAT Margin 19.0% 20.4% 17.6% 10.1% 15.8% 9.6% 9.8% 8.5% 1.0% 7.0% 4,045 4,320 3,580 3,163 729 713 682 349 342 304 2,396 455 229 318 32 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 R
Slide 31: Historical Profit & Loss
HISTORICAL PROFIT & LOSS Cr. Particulars FY25 FY24 FY23 FY22 FY21 Revenue from Operations 4,319.9 3,163.0 4,045.2 3,579.8 2,395.6 COGS 3,028.1 2,342.4 2,860.8 2,499.8 1,636.0 Gross Profit 1,291.8 820.6 1,184.4 1,080.0 759.7 Gross Margin % 29.9% 25.9% 29.3% 30.2% 31.7% Employee Expenses 52.0 42.4 44.
Slide 32: Balance Sheet – Equity & Liabilities
BALANCE SHEET – EQUITY & LIABILITIES Cr. Equities & Liabilities FY25 FY24 FY23 FY22 FY21 Shareholder's Funds Equity and Share Capital 90.2 90.2 90.2 90.2 90.2 Other Equity 2,410.4 2,146.9 2,141.8 1,822.2 1,524.1 Non-controlling Interest 0.4 0.4 0.4 0.3 0.3 Total Equity 2,501.0 2,237.5 2,232.4 1,912.
Slide 33: Balance Sheet – Assets
BALANCE SHEET – ASSETS Cr. ASSETS FY25 FY24 FY23 FY22 FY21 Assets Non-Current Assets Property, Plant and Equipment 3.0 3.8 5.0 14.4 20.9 Right to Use Assets 7.2 14.4 0.0 - - Goodwill 0.0 0.0 0.0 0.0 0.4 Other Intangible assets 740.2 690.0 663.0 577.4 523.1 Intangible assets under development 291.4 2
Slide 34: CSR Activities
CSR ACTIVITIES CSR initiatives taken up by the Company are in the areas of Promoting Education, Healthcare, Eradicating Hunger, Empowerment of Women, Animal Welfare, Promotion of Sports and Rural Development Projects Promoting Education Animal Welfare Medical Aid & Relief 33
Slide 35: Thank You
SECURING HARVESTS, NURTURING FUTURES. THANK YOU Company: Sharda Cropchem Limited Investor Relation Advisors: Strategic Growth Advisors Pvt. Ltd. CIN: L51909MH2004PLC145007 CIN: U74140MH2010PTC204285 Mr. Shailesh Mehendale – CFO Mr. Deven Dhruva cfo@shardaintl.com / finance@shardaintl.com deven.dhruv